NEW YORK, and PORTLAND, Ore., July 13, 2016 /PRNewswire/ -- Wellpartner (http://www.wellpartner.com), the proven authority in 340B program management and trusted strategic partner, announced today the appointment of Harish Thiagaraj as Senior Vice President of Wellpartner Pharmacy and Special Pharmacy.
Mr. Thiagaraj has over 12 years of experience in leading areas of clinical operations, managed care, specialty pharmacy strategy, pharmacoeconomics, sales and marketing. He has held leadership positions at several market leading retail and specialty pharmacy chains. A proven leader in identifying, innovating, and executing specialty pharmacy strategies, Mr. Thiagaraj will be responsible for all aspects of Wellpartner's URAC-accredited, specialty pharmacy operations.
"We are excited to welcome Harish to the Wellpartner team," said James Love, CEO of Wellpartner. "With his broad knowledge and experience working in this industry we are confident that, under Mr. Thiagaraj's leadership, Wellpartner is well positioned for continued growth in the specialty pharmacy arena."
About Wellpartner As your strategic partner, we're committed to providing a complete 340B service suite that creates value, and gets it right.
Wellpartner is the authority in 340B program management offering innovative technology and the broadest set of 340B services. By staying ahead of industry changes, Wellpartner provides a seamless, easy-to-use solution for covered entities currently or considering participating in the 340B Drug Program.
Our experience is your advantage. Our processes are finely-tuned towards achieving the best results for our customers, whether it is contracting, providing our URAC-accredited specialty pharmacy services, ensuring program compliance, aligning specialty network access, maximizing claims capture, or driving program value. Wellpartner is focused on excelling at these tasks, since we share the same goal as our covered entity customers—to preserve resources, in order to serve those who need it most.